The growth of bacteria in infusion drugs: propofol 2% supports growth when remifentanil and pantoprazole do not
Background and objectives: Contamination risks of propofol 2%, remifentanil, and pantoprazole; and in vitro effects of these drugs on the growth of common infective agents in intensive care units were evaluated. Methods: For detection of contamination risk, drugs were prepared ready to use under int...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2013-11-01
|
| Series: | Brazilian Journal of Anesthesiology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0104001413001759 |
| _version_ | 1811180342980116480 |
|---|---|
| author | Ismail Aydın Erden Dolunay Gülmez Almila Gulsun Pamuk Seda Banu Akincia Gülşen Hasçelik Ulkü Aypar |
| author_facet | Ismail Aydın Erden Dolunay Gülmez Almila Gulsun Pamuk Seda Banu Akincia Gülşen Hasçelik Ulkü Aypar |
| author_sort | Ismail Aydın Erden |
| collection | DOAJ |
| description | Background and objectives: Contamination risks of propofol 2%, remifentanil, and pantoprazole; and in vitro effects of these drugs on the growth of common infective agents in intensive care units were evaluated. Methods: For detection of contamination risk, drugs were prepared ready to use under intensive care unit conditions, were tested. Effects of these three drugs on bacterial growth were also investigated. Drugs were prepared at the concentrations used in the intensive care unit and inoculated with common pathogens after which they were incubated at 4 °C, 22 °C and 36 °C. Subcultures were made at 0, 2, 4 and 8 h and colony counts were evaluated. Minimum inhibitory concentration values were determined for all drugs at 4 °C, 22 °C and 36 °C. Results: No growth was observed in the drugs prepared in the intensive care unit. Propofol tended to support while remifentanil inhibited bacterial growth. Effect of pantoprozole differed according to the bacteria tested. None of the drugs showed antibacterial activity at the maximum concentrations which may be achieved in blood of the patients. Conclusion: Propofol strongly supports the growth of the microorganisms tested, although remifentanil and pantoprazole do not. Therefore, it is important to follow the strict aseptic techniques for the preparation of propofol. Keywords: Nosocomial infection, Propofol, Remifentanil, Pantoprozol, Bacterial growth |
| first_indexed | 2024-04-11T09:01:37Z |
| format | Article |
| id | doaj.art-4b357f7241ca40fe850b54090a3cfbf4 |
| institution | Directory Open Access Journal |
| issn | 0104-0014 |
| language | English |
| last_indexed | 2024-04-11T09:01:37Z |
| publishDate | 2013-11-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Brazilian Journal of Anesthesiology |
| spelling | doaj.art-4b357f7241ca40fe850b54090a3cfbf42022-12-22T04:32:46ZengElsevierBrazilian Journal of Anesthesiology0104-00142013-11-01636466472The growth of bacteria in infusion drugs: propofol 2% supports growth when remifentanil and pantoprazole do notIsmail Aydın Erden0Dolunay Gülmez1Almila Gulsun Pamuk2Seda Banu Akincia3Gülşen Hasçelik4Ulkü Aypar5Department of Anesthesiology and Reanimation, Faculty of Medicine, Hacettepe University, Ankara, Turkey; Corresponding author.Department of Medical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, TurkeyDepartment of Anesthesiology and Reanimation, Faculty of Medicine, Hacettepe University, Ankara, TurkeyDepartment of Anesthesiology and Reanimation, Faculty of Medicine, Hacettepe University, Ankara, Turkey; Department of Medical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, TurkeyDepartment of Medical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, TurkeyDepartment of Anesthesiology and Reanimation, Faculty of Medicine, Hacettepe University, Ankara, TurkeyBackground and objectives: Contamination risks of propofol 2%, remifentanil, and pantoprazole; and in vitro effects of these drugs on the growth of common infective agents in intensive care units were evaluated. Methods: For detection of contamination risk, drugs were prepared ready to use under intensive care unit conditions, were tested. Effects of these three drugs on bacterial growth were also investigated. Drugs were prepared at the concentrations used in the intensive care unit and inoculated with common pathogens after which they were incubated at 4 °C, 22 °C and 36 °C. Subcultures were made at 0, 2, 4 and 8 h and colony counts were evaluated. Minimum inhibitory concentration values were determined for all drugs at 4 °C, 22 °C and 36 °C. Results: No growth was observed in the drugs prepared in the intensive care unit. Propofol tended to support while remifentanil inhibited bacterial growth. Effect of pantoprozole differed according to the bacteria tested. None of the drugs showed antibacterial activity at the maximum concentrations which may be achieved in blood of the patients. Conclusion: Propofol strongly supports the growth of the microorganisms tested, although remifentanil and pantoprazole do not. Therefore, it is important to follow the strict aseptic techniques for the preparation of propofol. Keywords: Nosocomial infection, Propofol, Remifentanil, Pantoprozol, Bacterial growthhttp://www.sciencedirect.com/science/article/pii/S0104001413001759 |
| spellingShingle | Ismail Aydın Erden Dolunay Gülmez Almila Gulsun Pamuk Seda Banu Akincia Gülşen Hasçelik Ulkü Aypar The growth of bacteria in infusion drugs: propofol 2% supports growth when remifentanil and pantoprazole do not Brazilian Journal of Anesthesiology |
| title | The growth of bacteria in infusion drugs: propofol 2% supports growth when remifentanil and pantoprazole do not |
| title_full | The growth of bacteria in infusion drugs: propofol 2% supports growth when remifentanil and pantoprazole do not |
| title_fullStr | The growth of bacteria in infusion drugs: propofol 2% supports growth when remifentanil and pantoprazole do not |
| title_full_unstemmed | The growth of bacteria in infusion drugs: propofol 2% supports growth when remifentanil and pantoprazole do not |
| title_short | The growth of bacteria in infusion drugs: propofol 2% supports growth when remifentanil and pantoprazole do not |
| title_sort | growth of bacteria in infusion drugs propofol 2 supports growth when remifentanil and pantoprazole do not |
| url | http://www.sciencedirect.com/science/article/pii/S0104001413001759 |
| work_keys_str_mv | AT ismailaydınerden thegrowthofbacteriaininfusiondrugspropofol2supportsgrowthwhenremifentanilandpantoprazoledonot AT dolunaygulmez thegrowthofbacteriaininfusiondrugspropofol2supportsgrowthwhenremifentanilandpantoprazoledonot AT almilagulsunpamuk thegrowthofbacteriaininfusiondrugspropofol2supportsgrowthwhenremifentanilandpantoprazoledonot AT sedabanuakincia thegrowthofbacteriaininfusiondrugspropofol2supportsgrowthwhenremifentanilandpantoprazoledonot AT gulsenhascelik thegrowthofbacteriaininfusiondrugspropofol2supportsgrowthwhenremifentanilandpantoprazoledonot AT ulkuaypar thegrowthofbacteriaininfusiondrugspropofol2supportsgrowthwhenremifentanilandpantoprazoledonot AT ismailaydınerden growthofbacteriaininfusiondrugspropofol2supportsgrowthwhenremifentanilandpantoprazoledonot AT dolunaygulmez growthofbacteriaininfusiondrugspropofol2supportsgrowthwhenremifentanilandpantoprazoledonot AT almilagulsunpamuk growthofbacteriaininfusiondrugspropofol2supportsgrowthwhenremifentanilandpantoprazoledonot AT sedabanuakincia growthofbacteriaininfusiondrugspropofol2supportsgrowthwhenremifentanilandpantoprazoledonot AT gulsenhascelik growthofbacteriaininfusiondrugspropofol2supportsgrowthwhenremifentanilandpantoprazoledonot AT ulkuaypar growthofbacteriaininfusiondrugspropofol2supportsgrowthwhenremifentanilandpantoprazoledonot |